Sign in

The Lancet Respiratory Medicine

@lancetrespirmed.bsky.social
1.2K followers 157 following 259 posts

A unique and international medical journal for respiratory and critical care specialists. 🌐 www.thelancet.com/journals/lanres/h…

PostsRepliesMedia
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 01/10/2026
🗞️ News Our report from @europeanrespsoc.bsky.social #ERS2026 covers phase 3 data on tozorakimab, new data on ralinepag, high-dose influenza vaccine, astegolimab, and lunsekimig. Written by Priya Venkatesan Check out the full report: www.thelancet.com/journals/lan...
Caption        : Aerial view of Sitges downtown along the Mediterranean Sea coastline at night, Barcelona, Spain.
Credit         : Michele Rinaldi/Amazing Aerial Agency/SCIENCE PHOTO LIBRARY
000
Reposted by The Lancet Respiratory Medicine
TAGHIVscience @taghivscience.bsky.social · 24/09/2026
Duration of effectiveness of #tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis www.thelancet.com/journals/lan... (open access) @lancetrespirmed.bsky.social
thelancet.com
Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis
Among close contacts with evidence of M tuberculosis infection, we found that the initial protection from TPT eroded relatively quickly in high-burden settings, but was sustained long-term in medium-b...
012
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 01/10/2026
🫁 Explore our October 2026 issue, out now in print and online! www.thelancet.com/issue/S2213-... 🔹 This issue features our new Series on therapeutics in #lungcancer, the economic burden of #asthma, #tuberculosis in Ukraine, and much more
021
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 17/09/2026
🗞️ News #AI data centres could worsen US air pollution "AI firms are exploiting loopholes and lax air pollution enforcement in a race to build new on-site fossil-fuel power plants for data centres across the USA" Written by @bryantfurlow.bsky.social www.thelancet.com/journals/lan...
thelancet.com
AI data centres could worsen US air pollution
Artificial intelligence (AI) firms are exploiting loopholes and lax air pollution enforcement in a race to build new on-site fossil-fuel power plants for data centres across the USA. Concerns over air...
044
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 15/09/2026
🎙️ New Podcast: The changing treatment landscape in #LungCancer Solange Peters, Lizza Hendriks, and Martin Reck join Jonathan Blott to discuss our new joint Series with The Lancet on therapeutics in lung cancer, launched at #ERS2026. www.thelancet.com/audio-do/sol...
The image on the card is a screen with a control panel. A simulated treatment device features fader slots. Icons above each slot indicate different lung cancer treatment approaches.

Credit: Lillian Li
000
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 15/09/2026
📰 News: Unravelling of #tuberculosis control in Ukraine www.thelancet.com/journals/lan... Written by Talha Burki
MSF doctor in Ukraine.

Credit: Global Images Ukraine / Contributor
011
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 08/09/2026
❗ #ERSALERTS Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in children with cystic fibrosis aged 2–5 years (TIMBERLINE Trial VX21-121-105): a phase 3, open-label study Presented today by Prof Marcus Mall at #ERS2026 www.thelancet.com/journals/lan...
100
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 08/09/2026
📰 New Series from The Lancet and The Lancet Respiratory Medicine, launched 7th September at #ERS2026 Therapeutics in Lung Cancer www.thelancet.com/series-do/lu... The Series includes three review papers on early stage #NSCLC, advanced NSCLC, and #SCLC 🔓All content is free to access for all
Image of a computer screen and control panel, representing targeted, specific therapeutics for lung cancer.

Credit: Lillian Li
121
Reposted by The Lancet Respiratory Medicine
The Lancet @thelancet.com · 07/09/2026
🫁 Lung cancer remains the leading cause of cancer-related death worldwide. A new Lancet–@lancetrespirmed.bsky.social Series, presented at #ERSCongress, evaluates the evolving therapeutic landscape across the major subtypes of lung cancer: spkl.io/633247uqza @europeanrespsoc.bsky.social
Promotional card for The Lancet-Lancet Respiratory Medicine Series on Therapeutics in Lung Cancer. The image on the card is a screen with a control panel. A simulated treatment device features fader slots. Icons above each slot indicate different lung cancer treatment approaches. Copyright: Lillian Li.
0103
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 04/09/2026
🗓️ The Lancet Respiratory Medicine Team are looking forward to #ERS2026 in Barcelona from 5-9th September Please join us on Monday 7th September at 3:30 pm for the launch of our new joint Series with The Lancet on Therapeutics in #LungCancer @europeanrespsoc.bsky.social
Aerial view of Sitges downtown at night, Barcelona, Spain

Credit         : Michele Rinaldi/Amazing Aerial Agency/SCIENCE PHOTO LIBRARY
000
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 26/08/2026
🫁 Explore our September 2026 issue, out now in print and online! 🔗 www.thelancet.com/issue/S2213-... 🔹 This issue covers postoperative pulmonary complications, #NSCLC, pulmonary fibrosis of childhood #ILD and much more
Alt: In a children’s activity room, a pair of glass windows forms the shape of lungs, with dust covering the surface to represent pulmonary fibrosis. A child wipes away the dust and reveals other children outside the windows, symbolising the progress made through research and highlighting the need to bring greater attention to children affected by these conditions.

Credit: Lillian Li
001
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 21/08/2026
📮 New Article available #OpenAccess 📊 A patient-level meta-analysis of RCTs and cohort studies (7161 people) found ACQ-5 symptom scores barely tracked with inflammatory biomarkers. Blood eosinophils and FeNO, by contrast, reliably flagged both risk and treatment response. 🔗 tinyurl.com/3fpzbkp2
thelancet.com
Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies
In a large, individual patient-level meta-analysis of randomised controlled trials and translational prospective observational cohort studies, we observed little alignment of symptom burden with other...
000
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 20/08/2026
💡New Spotlight - Breathing Space: “A love letter to breath” Read how the Breathing Space Garden created space for previously unspoken experiences of lung disease to be voiced, heard, and understood Written by @katebinnie.bsky.social www.thelancet.com/journals/lan... @asthmaandlung.org.uk
thelancet.com
Breathing Space: “A love letter to breath”
It has been nearly 10 years since Havi Carel's Spotlight in The Lancet Respiratory Medicine on breathlessness and the rift between objective measurement and subjective experience. Havi's phenomenologi...
031
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 13/08/2026
📨 New Editorial 🔹Our latest editorial reviews evidence that wildfire-specific PM2·5 raises respiratory hospitalisation risk more than ordinary particulate pollution, hitting children, older adults, and low-income communities hardest. tinyurl.com/2sy2fmmr #Wildfires #ClimateChange
000
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 30/07/2026
❇️ New Article available #OpenAccess Why does #asthma cost the US economy roughly 100 times more than it costs low-income countries — even though LMICs carry the larger share of the disease burden? Read the full paper: www.thelancet.com/journals/lan...
001
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 29/07/2026
📊 The August issue of The Lancet Respiratory Medicine is out — from equitable #ILD care to new trial data in children's oxygen therapy, severe #asthma biologics, and reproductive health in #cysticfibrosis. Check out the full issue here: www.thelancet.com/issue/S2213-...
020
Reposted by The Lancet Respiratory Medicine
The Lancet @thelancet.com · 23/07/2026
🔔 Discover The Lancet Surgery & Anaesthesiology, a new journal with a sharp clinical focus, dedicated to advancing science across the full extent of #surgery, #anaesthesiology, and #perioperative specialties, across the age spectrum, and across the globe: spkl.io/633237JQbc
Illustration of a female in green scrubs, cap, and blue surgical mask, surrounded by four smaller illustrations showing surgical instruments and operating room scenes. Copyright: Grace Russell.
1710
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 23/07/2026
📊 New Article available #OpenAccess 📈 FEF25–75% trajectories from age 7 to 53 years, associations with childhood and parental preconception factors, and midlife COPD risk: a prospective cohort study Could your risk of #COPD be shaped before you were even born? www.thelancet.com/journals/lan...
101
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 16/07/2026
Does transformative CF treatment mean transformative reproductive outcomes — and why does the answer differ for men and women? Read the full paper: www.thelancet.com/journals/lan... #CysticFibrosis #CFTRModulators #ReproductiveHealth #LancetRespiratoryMedicine #Pulmonology #WomensHealth #CFCare
010
Reposted by The Lancet Respiratory Medicine
Pulmonology Advisor @pulmonologyadvisor.bsky.social · 07/07/2026
From @lancetrespirmed.bsky.social 🫁 #Sugammadex decreased the incidence of postoperative pulmonary complications or mortality compared with #neostigmine in older adults who had major abdominal or #ThoracicSurgery under #GeneralAnesthesia. @katy-skier.bsky.social @prof-nancy-devlin.bsky.social
pulmonologyadvisor.com
Postoperative Pulmonary Complications: Sugammadex Outperforms Neostigmine
Sugammadex lowers the risk for postoperative pulmonary complications vs neostigmine after major abdominal or thoracic surgery in older adults.
022
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 02/07/2026
📮 July issue out now! Check out the full issue here: www.thelancet.com/issue/S2213-... 📜 Editorial - Dying with Dignity—time to cut the red tape www.thelancet.com/journals/lan... 📰 News Barriers limit oxygen therapy in Nigeria, Kenya, and Uganda by Paul Adepoju www.thelancet.com/journals/lan...
Credit: Lillian Li
022
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 02/07/2026
We are the world-leading journal, ranking #1 in:   Journal Impact Factor (34·7) in respiratory system and #CriticalCareMedicine  Scopus CiteScore (48·1) in pulmonary and #RespiratoryMedicine  Explore our high impact and global reach: hubs.li/Q04k_nNQ0    #Pulmonology #pulmcc
hubs.li
About The Lancet Respiratory Medicine
130
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 02/07/2026
Peer review is stronger when reviewers reflect the breadth of global health expertise. If you author or review for a Lancet journal, update your Editorial Manager profile with your health equity & discrimination expertise. tinyurl.com/yrxfvsbm
Alt text: Social media card with a blue faded background and up-close image of a laptop key embossed with the word “Update”. Overlay text reads, “Your expertise matters. Help us connect submissions with the right reviewers — update your Editorial Manager profile.”
110
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 25/06/2026
🗞️ News - Trump Administration sparks furore and resignations over fruit-flavoured #vape authorisations 🔹 White House overrules objections from FDA commissioner, ordering the agency to authorise two fruit-flavoured #eCigarette products @bryantfurlow.bsky.social 🖇️ www.thelancet.com/journals/lan...
thelancet.com
Trump Administration sparks furore and resignations over fruit-flavoured vape authorisations
On May 5, the White House overruled objections from US Food and Drug Administration (FDA) commissioner Marty Makary and ordered the agency to authorise sales of two fruit-flavoured e-cigarette product...
011
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 25/06/2026
New Article available #OpenAccess 📌 Prevalence and disease trajectories of pulmonary fibrosis of childhood interstitial lung disease: a register-based, multicentre observational study #ILD #chILD #PulmonaryFibrosis 🖇️ www.thelancet.com/journals/lan...
000
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 18/06/2026
🎙️New Podcast Andrew Bush, Heather Zar, and Fernando de Benedictis on how inhaled corticosteroids have changed the treatment of asthma www.thelancet.com/audio-do/and... Check out the full paper here: www.thelancet.com/journals/lan...
thelancet.com
50 years on: how inhaled corticosteroids have changed the treatment of asthma
Inhaled corticosteroids are the foundation of asthma therapy and now, 50 years on from their introduction, is an appropriate time to summarise some of the key studies that have progressed the field. W...
000
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 18/06/2026
📊 New Article available #OpenAccess 📌Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial 🔗 www.thelancet.com/journals/lan...
thelancet.com
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial
Sugammadex reduced the incidence of postoperative pulmonary complications or death compared with neostigmine. The risk reduction was small with atelectasis of uncertain clinical significance being the...
010
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 18/06/2026
Today is #CleanAirDay Read our latest Editorial - Clean Air Day: breathe locally, plan globally www.thelancet.com/journals/lan...
Polluted image of Paris
Credit: VOISIN/PHANIE/SCIENCE PHOTO LIBRARY
000
Reposted by The Lancet Respiratory Medicine
Pulmonology Advisor @pulmonologyadvisor.bsky.social · 17/06/2026
From @lancetrespirmed.bsky.social 🫁 The link between 60-day mortality and personalized, best-practice mechanical ventilation in patients with #AcuteRespiratoryDistressSyndrome may be stronger in those with hypoinflammatory vs hyperinflammatory ARDS.
pulmonologyadvisor.com
In ARDS, Mortality Risk With Mechanical Ventilation Varies by Phenotype
The link between 60-day mortality and MV in patients with ARDS may be stronger in those with hypoinflammatory vs hyperinflammatory ARDS.
001
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 12/06/2026
💡 New Spotlight: Africa's inhaler dilemma Esther Nakkazi reports on the issues of cost, climate, and care www.thelancet.com/journals/lan...
thelancet.com
Africa's inhaler dilemma: balancing cost, climate, and care
When baby Sidrah Isaacs was born, she appeared well. At around 6 weeks of age, her mother, Sasha Leigh, began to notice concerning symptoms, including a silent cough, a weak cry, and breathing difficu...
010
Reposted by The Lancet Respiratory Medicine
ANZCA @anzca.bsky.social · 10/06/2026
It's official! The SNaPP trial @anzcactn.bsky.social findings are out, published today @lancetrespirmed.bsky.social, a four year trial with principal investigator @katy-skier.bsky.social.
anzca.edu.au
Global study highlights hidden pandemic of lung complications - ANZCA
A “hidden pandemic” of lung complications after surgery has been highlighted by an international study led by Australian anaesthetists that has found how a newer muscle relaxant reversal drug can help...
035
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 12/06/2026
🌅 Check out the #SUNRISE phase 3 trial of tezepelumab in reducing OCS use in severe, OCS-dependent #asthma 🟥Efficacy and safety of tezepelumab vs placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent #asthma (SUNRISE) tinyurl.com/6h8xtr8w
thelancet.com
Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-b...
In this study, tezepelumab treatment led to greater reductions from baseline in daily oral corticosteroid dose than placebo at week 28 despite early study termination. No safety concerns were identifi...
001
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 03/06/2026
🏥 June issue of The Lancet Respiratory Medicine available online and in print now! Check out the full issue here: www.thelancet.com/issue/S2213-... 📜 Editorial Clean Air Day: breathe locally, plan globally www.thelancet.com/journals/lan...
Credit: Lillian Li
000
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 02/06/2026
🗞️ News: 2026 #GINA report for #asthma On May 5, 2025, the Global Initiative for Asthma published the 2026 update to their Global Strategy for Asthma Management and Prevention. Check out the major updates here: www.thelancet.com/journals/lan... Written by Priya Venkatesan
thelancet.com
2026 GINA report for asthma
On May 5, 2025, the Global Initiative For Asthma (GINA) published the 2026 update to their Global Strategy for Asthma Management and Prevention. On the same date, an online discussion hosted by GINA p...
010
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 02/06/2026
📰 New Correspondence: Toxic skies of war "Environmental agencies and health organisations should address war as a dimension of increased environmental risk and hold those responsible to account for the environmental damage caused by warfare actions." www.thelancet.com/journals/lan...
thelancet.com
Toxic skies of war
Recent reports indicate that the burden of chronic respiratory diseases has increased by 80% in the Middle East and Northern Africa region between 1990 and 2019,1 and air pollution in the region, part...
000
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 01/06/2026
🚨New Article #OpenAccess #Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study) Findings suggested that eosinophilic inflammation is not involved in exacerbations when a patient is being treated with benralizumab www.thelancet.com/journals/lan...
thelancet.com
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
Our findings suggested that eosinophilic inflammation is not involved in exacerbations when a patient is being treated with benralizumab. Airway neutrophilia, viral pathogens, and alteration of the sp...
010
Reposted by The Lancet Respiratory Medicine
The Lancet @thelancet.com · 14/05/2026
Inhaled corticosteroids are the foundation of asthma therapy and play a crucial role in reducing the risk of asthma attacks. In @lancetrespirmed.bsky.social, a Personal View discusses how inhaled corticosteroids have changed asthma treatment over the last 50 years: spkl.io/63323ACkhX
Figure: Timeline of the landmark studies of inhaled corticosteroids. Copyright: Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
032
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 13/05/2026
🗞️ News: Barriers limit oxygen therapy in Nigeria, Kenya, and Uganda 🔹 WHO classifies medical oxygen as an essential medicine, yet access remains persistently unequal across settings. 🖇️ www.thelancet.com/journals/lan... Written by Paul Adepoju
Medical oxygen canisters in green box.

Credit: Science Photo Library
001
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 07/05/2026
🚨 New publication alert 📈 Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study 🖇️ www.thelancet.com/journals/lan...
thelancet.com
Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study
Ventilation management in children varies substantially by age and PARDS status. Among potentially modifiable ventilation factors, only PEEP, ΔP, and FiO2 were associated with 28-day mortality.
010
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 05/05/2026
📰 Check out our comprehensive new Review 🏥 Respiratory infections due to human common cold coronaviruses, #SARS-CoV, #MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes 🖇️ www.thelancet.com/journals/lan...
thelancet.com
Respiratory infections due to human common cold coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes
Over the past half-century, perceptions of human coronaviruses have evolved from their initial characterisation as causes of the common cold to recognition of their capacity to trigger severe disease ...
032
Reposted by The Lancet Respiratory Medicine
Gabriele Pollara @gpollara.bsky.social · 21/04/2026
Here is the paper @lancetrespirmed.bsky.social (3/3) #IDSky #TBSky www.thelancet.com/journals/lan...
thelancet.com
Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial
Using WGS and AI to select regimens with optimal drug features had similar bacteriological and superior clinical efficacy compared with standard of care and was safe. Future trials should evaluate the...
141
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 29/04/2026
📰 Explore The Lancet Respiratory Medicine’s May 2026 issue, out now online and in print: www.thelancet.com/journals/lan... 📜 Our Editorial this month is on "Campaigning to improve #sepsis recognition and outcomes" www.thelancet.com/journals/lan...
Conceptual image of a multidisciplinary team discussing a puzzle of techniques for the lung.
Cover by Lillian Li
011
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 20/04/2026
📜New Editorial: Campaigning to improve #sepsis recognition and outcomes Read in full here: www.thelancet.com/journals/lan...
thelancet.com
Campaigning to improve sepsis recognition and outcomes
Sepsis accounts for around a third of global deaths, with an estimated 166 million cases and 21·4 million all-cause sepsis-related deaths according to a recent study from the Global Sepsis Collaborato...
020
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 02/04/2026
🍃 Our April Issue is out now! Check out the full issue here: www.thelancet.com/issue/S2213-... The issue features three key Articles, available #OpenAccess, as well as News on tobacco control in the US and Asthma in India
Credit: Lillian Li
Alt: A matchbox containing two sets of chromosome-shaped matches in different colours and sizes: red for normal telomeres and yellow for shortened telomeres. A sticker on the box illustrates a healthy red lung and a damaged yellow lung.
110
Reposted by The Lancet Respiratory Medicine
COPD Athlete @copdathlete.bsky.social · 27/03/2026
Thank you to @lancetrespirmed.bsky.social for sharing my story. #COPD www.thelancet.com/action/showP...
thelancet.com
Russell Winwood: “COPD Athlete” defying views on lung disease
Russell Winwood's chronic obstructive pulmonary disease (COPD) diagnosis in 2011 was a brutal wake-up call. His second in less than a decade. The Brisbane native, who came to be known as the “COPD Ath...
021
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 31/03/2026
🏥 New: Position Paper on #NSCLC 📰 Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration 🔗 www.thelancet.com/journals/lan...
thelancet.com
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration
The decision regarding resectability in stage III non-small-cell lung cancer (NSCLC) is complex. To improve consistency in eligibility criteria in clinical trials, the European Organisation for Resear...
130
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 26/03/2026
📊 Round up of The Lancet Respiratory Medicine content presented at #SCCM 🏥 Wonderful to see so many advances presented during the congress, continuing progress in #CriticalCare #ARDS #SEPSIS #BRONCHIOLITIS @sccmcriticalcare.bsky.social
Alt: aerial view of Chicago skyscrapers covered in cloud, with orange to blue sunset colours

Credit: Razvan Sera/Amazing Aerial Agency/Science Photo Library
120
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 25/03/2026
🚨 Conference Alert: New Article Available Open Access @sccmcriticalcare.bsky.social 📊 Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study #ARDS #Sepsis #SCCM 🔓 tinyurl.com/mwvtjub3 📰 Linked Comment: tinyurl.com/yy2aps7m
010
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 25/03/2026
🖇️ New Article presented at #SCCM 📊 Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of #sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a phase 3 RCT 🔓 Read here: tinyurl.com/2h7dw8xx
000
Reposted by The Lancet Respiratory Medicine
Madhu Pai, MD, PhD @madhupai.bsky.social · 24/03/2026
#WorldTBDay @lancetgh.bsky.social podcast on tuberculosis, with host @gavincleaver.bsky.social www.buzzsprout.com/1358155/epis...
buzzsprout.com
Madhukar Pai on tuberculosis - The Lancet Global Health in conversation with
What systems fix would unlock the biggest equity gains? Should countries target patients with TB or conduct universal interventions? What does self-reliance look like post-aid cuts? Madhukar Pai joins...
096